Vertex Pharmaceuticals: 9th week, +21% since entry
Vertex Pharmaceuticals stock gains 8.4% and nears its all-time highs
Our view last week
Vertex Pharmaceuticals stock gains 2% this past week and climbs back near its three-month highs. Our weekly technical analysis flags one detail worth watching, though: in the last bar sellers turned dominant again and buying pressure is easing. The buy signal is now in its 8th week, with the trade up nearly 12% since entry.
This week's summary
Vertex Pharmaceuticals stock gains 8.4% this past week and climbs back within reach of its all-time highs, though in the last bar buying pressure eased and the weekly RSI rose to 69, close to overbought. Our weekly technical analysis flags the buy signal now in its 9th week, up 21.4% since entry, with the stock having already tested the highs once.
IQS Phase
71
in tension
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#27 / 167
US stocks in progress
Trade P&L %
+21.35%
from signal to date, no stop loss
Rank position
ranks 27th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 66 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
VRTX belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content